Table 1.
Summary of coronary stent studies used for treatment of intracranial stenosis.
Study | Type | Subjects | 30-day outcomes | Long-term outcomes | Restenosis rates |
---|---|---|---|---|---|
Mori et al. (2000) | Retrospective | 10 | No stroke or death | No ischemic events at 11 months | No restenosis at 3 months |
Gomez et al. (2000) | Retrospective | 12 | No stroke or death | 2 patients had a TIA at 6 months | 2/12 had F/U, 1 had basilar occlusion at 4 months |
Mazighi et al. (2008) | Retrospective | 53* | 10% stroke or death | 6% TIA or stroke at 2 years | 16% at 1 year |
Abou-Chebl et al. (2005)** | Retrospective | 8 | 1 patient had TIA | No stroke or TIAs at 11 months | No restenosis at 10 months |
Qureshi et al. (2006)** | Retrospective | 18 | 1 stroke, no deaths | 22% at 14 months | 14% at 14 months |
Gupta et al. (2006)** | Retrospective | 26 of 29 attempted | 12% stroke or dissection | 5% stroke at 4 months | 5% at 4 months |
Steinfort et al. (2007)** | Retrospective | 13 | 8% stroke | 8% stroke at 11 months | 9/12 had F/U with 0% at 5 months |
Natarajan et al. (2010)*** | Retrospective | 6 | 17% stroke | 0% at 4–10 months | 0% at 6 months |
*Only 76% of patients were treated with stents.
**Studies using drug-eluting stents.
***Second generation drug-eluting stent.